Bio Osmo Bhd. said its normalized net income for the third quarter was a loss of 34,130 ringgits, compared with a loss of 835,130 ringgits in the prior-year period.
Normalized net income excludes unusual gains or losses on a pre- and after-tax basis.
The normalized profit margin increased to negative 2.2% from negative 168.0% in the year-earlier period.
Total revenue increased year over year to 1.5 million ringgits from 497,000 ringgits, and total operating expenses declined 10.4% on an annual basis to 1.7 million ringgits from 1.9 million ringgits.
Reported net income totaled a loss of 111,000 ringgits, or a loss of 0 sen per share, compared to a loss of 1.4 million ringgits, or a loss of 0 sen per share, in the year-earlier period.
As of Nov. 24, US$1 was equivalent to 4.22 ringgits.